- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-trimer
- Ligands
- 9 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA.4: 6 residues within 4Å:- Chain A: V.1201, N.1202
- Chain B: D.869, D.871, N.872, Q.992
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:N.872, B:D.869
NAG-NAG-BMA.8: 6 residues within 4Å:- Chain B: V.1201, N.1202
- Chain C: D.869, D.871, N.872, Q.992
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:N.872, C:D.869
NAG-NAG-BMA.12: 6 residues within 4Å:- Chain A: D.869, D.871, N.872, Q.992
- Chain C: V.1201, N.1202
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:N.872, A:D.869
- 30 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.13: 2 residues within 4Å:- Chain A: N.6, N.9
Ligand excluded by PLIPNAG.14: 2 residues within 4Å:- Chain A: N.45, N.259
Ligand excluded by PLIPNAG.15: 3 residues within 4Å:- Chain A: H.129, V.132, N.175
Ligand excluded by PLIPNAG.16: 3 residues within 4Å:- Chain A: N.179, S.181, T.182
Ligand excluded by PLIPNAG.17: 4 residues within 4Å:- Chain A: S.234, N.235, T.236, N.238
Ligand excluded by PLIPNAG.18: 2 residues within 4Å:- Chain A: V.651, N.653
Ligand excluded by PLIPNAG.19: 2 residues within 4Å:- Chain A: H.671, N.673
Ligand excluded by PLIPNAG.20: 1 residues within 4Å:- Chain A: N.767
Ligand excluded by PLIPNAG.21: 1 residues within 4Å:- Chain A: N.784
Ligand excluded by PLIPNAG.22: 4 residues within 4Å:- Chain A: E.911, A.912, N.915, S.920
Ligand excluded by PLIPNAG.24: 2 residues within 4Å:- Chain B: N.6, N.9
Ligand excluded by PLIPNAG.25: 2 residues within 4Å:- Chain B: N.45, N.259
Ligand excluded by PLIPNAG.26: 3 residues within 4Å:- Chain B: H.129, V.132, N.175
Ligand excluded by PLIPNAG.27: 3 residues within 4Å:- Chain B: N.179, S.181, T.182
Ligand excluded by PLIPNAG.28: 4 residues within 4Å:- Chain B: S.234, N.235, T.236, N.238
Ligand excluded by PLIPNAG.29: 2 residues within 4Å:- Chain B: V.651, N.653
Ligand excluded by PLIPNAG.30: 3 residues within 4Å:- Chain B: H.671, N.673, Y.734
Ligand excluded by PLIPNAG.31: 1 residues within 4Å:- Chain B: N.767
Ligand excluded by PLIPNAG.32: 1 residues within 4Å:- Chain B: N.784
Ligand excluded by PLIPNAG.33: 4 residues within 4Å:- Chain B: E.911, A.912, N.915, S.920
Ligand excluded by PLIPNAG.35: 2 residues within 4Å:- Chain C: N.6, N.9
Ligand excluded by PLIPNAG.36: 2 residues within 4Å:- Chain C: N.45, N.259
Ligand excluded by PLIPNAG.37: 3 residues within 4Å:- Chain C: H.129, V.132, N.175
Ligand excluded by PLIPNAG.38: 3 residues within 4Å:- Chain C: N.179, S.181, T.182
Ligand excluded by PLIPNAG.39: 4 residues within 4Å:- Chain C: S.234, N.235, T.236, N.238
Ligand excluded by PLIPNAG.40: 2 residues within 4Å:- Chain C: V.651, N.653
Ligand excluded by PLIPNAG.41: 2 residues within 4Å:- Chain C: H.671, N.673
Ligand excluded by PLIPNAG.42: 1 residues within 4Å:- Chain C: N.767
Ligand excluded by PLIPNAG.43: 1 residues within 4Å:- Chain C: N.784
Ligand excluded by PLIPNAG.44: 4 residues within 4Å:- Chain C: E.911, A.912, N.915, S.920
Ligand excluded by PLIP- 3 x 01: 5-acetamido-8-O-(5-acetamido-9-O-acetyl-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl)-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranosonic acid
01.23: 13 residues within 4Å:- Chain A: N.13, L.15, T.17, L.66, K.67, G.68, T.69, W.76, N.230, A.231, I.232, S.233, N.235
10 PLIP interactions:10 interactions with chain A- Hydrophobic interactions: A:L.15, A:L.66, A:W.76
- Hydrogen bonds: A:K.67, A:K.67, A:T.69, A:T.69, A:S.233, A:N.235
- Salt bridges: A:K.67
01.34: 11 residues within 4Å:- Chain B: N.13, L.15, T.17, L.66, K.67, T.69, W.76, A.231, I.232, S.233, N.235
12 PLIP interactions:12 interactions with chain B- Hydrophobic interactions: B:L.15, B:L.66, B:W.76, B:N.235
- Hydrogen bonds: B:K.67, B:K.67, B:T.69, B:T.69, B:S.233, B:N.235, B:N.235
- Salt bridges: B:K.67
01.45: 11 residues within 4Å:- Chain C: L.15, T.17, L.66, K.67, T.69, W.76, N.230, A.231, I.232, S.233, N.235
11 PLIP interactions:11 interactions with chain C- Hydrophobic interactions: C:L.15, C:L.66, C:W.76
- Hydrogen bonds: C:K.67, C:K.67, C:T.69, C:T.69, C:T.69, C:S.233, C:N.235
- Salt bridges: C:K.67
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Jin, M. et al., Human coronavirus HKU1 spike structures reveal the basis for sialoglycan specificity and carbohydrate-promoted conformational changes. Nat Commun (2025)
- Release Date
- 2025-05-14
- Peptides
- Spike glycoprotein: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
BB
CC
A
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-trimer
- Ligands
- 9 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 30 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x 01: 5-acetamido-8-O-(5-acetamido-9-O-acetyl-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl)-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranosonic acid
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Jin, M. et al., Human coronavirus HKU1 spike structures reveal the basis for sialoglycan specificity and carbohydrate-promoted conformational changes. Nat Commun (2025)
- Release Date
- 2025-05-14
- Peptides
- Spike glycoprotein: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
BB
CC
A